SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Third Quarter 2022 Financial Results to be Announced in Early November
DALLAS, Oct. 18, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its borrower partners, including recent transactions and activities.
"The second half of 2022 has been an active time for SWK. We have capitalized on our strong underlying business fundamentals to close several transactions, including two $25.0 million financings with Aziyo Biologics and MedMinder," stated Jody Staggs, President and Interim CEO of SWK.
